If you would like to place an ad on this page for a job opening you have at your organization, please download the agreement form (.DOC – .PDF) for the posting criteria and submit it, along with the job description, to firstname.lastname@example.org.
If you have any questions, please contact SITC at email@example.com or call 414-271-2456.
The Developmental Therapeutics Program (DTP), of the NCI, is seeking candidates with an advanced degree in Biology, Microbiology, or equivalent for the position of Branch Chief, Biological Resources Branch (BRB).
The candidate will be a Supervisory Biologist directing the activities of the BRB (https://ncifrederick.cancer.gov/research/brb/) and will collaborate with investigators of the NCI DTP (https://dtp.cancer.gov/). The candidate will manage and coordinate all functional requirements for the branch including preclinical development research, clinical manufacturing and testing of biopharmaceutical products, and related studies pertaining to the extramural work of the BRB. The agents to be developed and manufactured in this program are biopharmaceutical and immunotherapy agents including, but not limited to, recombinant proteins, peptides, vaccines, monoclonal antibodies, genetically modified viruses, bacteria or mammalian cells, immunomodulating agents, cytokines and growth factors, tumor antigens, and nanotechnology-based biopharmaceutical products. The Chief manages and coordinates a system of grants and contracts to discover, investigate, develop and bring to initial clinical trials selected biologics and biopharmaceuticals with the intent of producing a therapeutic affect that alters the biology of cell growth and metastasis.
This is an exploratory ad to gauge interest and a possible candidate pool. A vacancy announcement (VA) to fill the position will be posted on WWW.USAJOBS.GOV at a later date.
Candidates must be U.S. citizens. Compensation for this position is commensurate with the individual’s qualifications and experience as permitted within Federal Government appointments.
Please submit your C.V., a statement of interest, and contact information for three references to Dr. Rosemarie Aurigemma, Developmental Therapeutics Program, National Cancer Institute at firstname.lastname@example.org (phone 240-276-5465).
DHHS, NIH, and NCI are Equal Opportunity Employers.
The Developmental Therapeutics Program (DTP), of the NCI, is seeking candidates with an advanced degree in Toxicology, Pharmacology, or equivalent for the position of Branch Chief, Toxicology and Pharmacology Branch (TPB).
The candidate will be a Supervisory Toxicologist directing the activities of the TPB (https://dtp.cancer.gov/organization/tpb/) and will collaborate with investigators of the NCI DTP (https://dtp.cancer.gov/). The candidate will manage and coordinate all functional requirements for the branch including formulation of research and/or testing the biological, toxicological, carcinogenic potential of chemicals, and/or biopharmaceutical agents and make recommendations for the development of new or revised programs to meet existing needs in the areas of toxicology, pharmacology, and pharmacodynamics.
The candidate initiates and develops research projects investigating mechanisms underlying the toxicity of chemicals, classes of chemicals, or other agents or important topics related to cancer therapeutics research. Candidates with interest in developing model systems for predicting and measuring toxicological and pharmacological properties of anticancer agents are of particular interest.
Please submit your C.V., a statement of interest. and contact information for three references to Dr. Rosemarie Aurigemma, Developmental Therapeutics Program, National Cancer Institute at email@example.com (phone 240-276-5465).
The Department of Laboratory Medicine at Memorial Sloan Kettering Cancer Center, New York seeks a Clinical Laboratory Immunologist. The Memorial Hospital for Cancer and Allied Diseases is a worldwide leader in cancer treatment and diagnosis, consistently voted as one of the best specialty hospitals in the nation. The Department of Laboratory Medicine provides diagnostic testing for all patients seen at Memorial Sloan Kettering Cancer Center (MSKCC). The Department is comprised of the following services: Clinical Chemistry, including Point-of Care, Hematology, including Coagulation and Cellular Immunology, Microbiology, Cellular Therapy, Transfusion Medicine, including blood bank, donor room and apheresis, and jointly with the Pathology Department, Hematopathology. The main campus operation is comprised of seven laboratories and the highest-volume hospital-based blood donor room in the City of New York. In addition, there are six regional sites located in New Jersey, Westchester, Long Island and several outpatient sites in Manhattan that collect specimens and perform limited testing on site.
The Cellular Immunology Laboratory performs over 35 thousand tests annually and is a highly advanced laboratory with a staff of 15 technologists, a supervisor, manager, and one Medical Service Chief. The environment provides substantial opportunities for clinical/translational research, as well as collaboration with investigators throughout MSKCC. The successful candidate will have the opportunity to participate in an expanding program focused on service, research and teaching. Several programs at Memorial Hospital are currently expanding resulting in increased tests volumes. The Department of Laboratory Medicine is concurrently expanding to support these new and expanding hospital programs that include a new, state-of-the art Lab Medicine building with dedicated laboratory space for individual areas.
Candidates must have an MD and/or PhD with expertise in cellular immunology including flow cytometry and functional/cytotoxic assays, particularly as they apply to the analysis of hematopoietic stem cell transplantation, immune reconstitution and immune modulation. Candidates must also have expertise in innate and humoral immunity, particularly related to clinical test utilization and assay development. Board Certification from the American Board of Clinical Laboratory Immunology is preferred and Board Certification from the American Board of Histocompatibility and Immunogenetics would be a plus. An additional requirement is the ability to obtain a NYS DOH COQ covering the relevant categories.
Applicants should send CV and cover letter describing personal area(s) of interest and long-term career goals to:
Melissa S Pessin, MD PhDChair, Department of Laboratory MedicineMemorial Sloan Kettering Cancer CenterCenter for Laboratory Medicine327 East 64th Street, Fifth Floor, Room 542New York, NY 10065email: firstname.lastname@example.org
Postdoctoral Associate Position in Tumor Immunology/Immunotherapy at the Duke Cancer Institute.
The Hanks Lab is a basic/translational research lab in the Duke Cancer Institute with an interest in understanding cancer immune evasion and immunotherapy resistance. We are seeking a motivated, hardworking Post-Doctoral Candidate with a background in immunology to take a leadership role in projects focused on understanding the role of the tumor microenvironment on immunotherapy resistance. This will be a two-year minimum position. The candidate will be expected to work independently but capable of collaborating with other lab members in a team-oriented work environment. Recent Ph.D. graduates preferred. http://www.thehankslab.com
Interested candidates should send CVs to Dr. Brent A. Hanks at email@example.com for consideration. Select candidates will undergo a phone interview and finalists will be interviewed in-person at Duke University.
Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200 clinical trials in 19 different types of cancer. AbbVie is expanding its oncology organization focusing on the discovery and development of novel oncology therapies. More than 1,000 AbbVie scientists, clinicians, and product developers with strong entrepreneurial roots combine their expertise in immuno-oncology, stem cells, apoptosis and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments.
The Translational Modeling & Simulation department within the Drug Metabolism and Pharmacokinetics (DMPK) group is searching for a DMPK project representative in South San Francisco to provide project support enabling biologics progression (incl. antibody-drug conjugates (ADCs) and bi-specifics) in Oncology discovery and clinical development. The scientist will collaborate closely with Discovery project teams; developing and executing the DMPK and PKPD strategies necessary to facilitate the advancement of optimized candidate molecules.
The Haura lab has an opening for a postdoctoral scholar in tumor immunology research. We pursue an interdisciplinary approach spanning immune biology and proteogenomics to characterize tumor immune states and response to immune therapy. We are looking for a highly motivated and independent postdoctoral research fellow who is interested in working on a project related to tumor neoantigens that predict response to tumor infiltrating lymphocytes and PD1 checkpoint therapy in lung cancer patients.
This individual will design, conduct and interpret correlative experiments using human samples from accruing immunotherapy clinical trials, in particular a trial using adoptive cell transfer of tumor infiltrating lymphocytes (TIL). This individual will identify and validate predicted neoantigens from lung cancer immunotherapy trials using novel functional assays. The candidate will have immediate access to rich array of patient samples including frozen tumor and tumor cell suspensions, and apheresis products and will join a productive, energetic team of immunologists, bioinformaticians, clinicians, surgeons, and protein researchers within our group.
The Ideal Candidate:
Successful candidates will have a publication track record demonstrating a strong background in in tumor immunology and/or immune-therapy; with an interest in translational research. Prior experience is required with some of the following techniques: high-throughput screening, mammalian cell culture, cell transfection assays, flow cytometry (FACS). Expertise in molecular biology (cloning, plasmid purification), and extraction of nucleic acids and protein from patient tissue samples is highly preferred. Candidates with experience in validating neoantigens in model systems will be given priority.u
Candidates with experience in cell culture, gene manipulation in cancer cells, cloning, T-cell activation assays or other immune cell based assays, and DNA/RNA/protein isolation techniques will be given preference.
Credentials and Qualifications:
M.D. or PhD in Molecular Biology, Immunology, Biochemistry, or relevant field.
Interested applicants should send their current CV with recent publications and contact information for three references to Dr. Eric Haura at Eric.Haura@moffitt.org
Moffitt Cancer Center is a premier cancer research institution in the United States. Built in an attractive location, it is the only NCI-designated cancer center in Florida and one of the top institutions in systems medicine and personalized cancer therapy. Moffitt features a number of high-quality core facilities equipped with state-of-the-art instrumentation and a cluster of expertise particularly in adoptive cell therapies.
The Neuro-Oncology Branch (NOB), Center for Cancer Research (CCR) of the National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (HHS), Bethesda, MD, is actively recruiting for a tenure-track principal investigator to work in the area of immunology and/or immunotherapy. The NOB Immunology/Immunotherapy Investigator will be tasked with forming and leading an independent research program. This position will build the basic immunology program in the NOB and complement ongoing and planned translational research and clinical trials evaluating the effects of immunotherapy in patients with primary brain tumors. This program will be able to access biospecimens generated from ongoing and planned immunotherapy protocols within the NOB, thus creating an opportunity to perform correlative studies to interrogate the complex biology of immunologic response, toxicity, and treatment resistance. Demonstrated expertise in scientific inquiries in immunotherapy and/or immunology are essential, but prior work in brain tumors is not required. This is an exciting opportunity to join a growing trans-institutional research team that promotes and supports collaborations across the basic, translational, and clinical research spectrum to develop novel therapeutics for individuals with primary central nervous system malignancies that will globally influence the field.
About NCI's Center for Cancer Research
The CCR is an intramural research component of the NCI. The CCR’s enabling infrastructure facilitates clinical studies at the NIH Clinical Center, the world’s largest dedicated clinical research complex; and provides extensive opportunities for collaboration with other investigators at the forefront of medical research. This environment enables scientists and clinicians to undertake high-risk, high-impact, laboratory- and clinic-based investigations. Investigators are supported by a wide array of intellectual, technological, and research resources. This includes surgical and pathology facilities; animal facilities; and dedicated, high-quality technology cores. For an overview of CCR, please visit: http://ccr.cancer.gov/. Access to core research support is also available to NCI CCR investigators through the Office of Science and Technology Resources (OSTR) that identifies, evaluates, and makes available new technologies and scientific resources. For more information of OSTR, please visit: https://ostr.cancer.gov/resources. The NCI Center of Excellence in Immunology (CEI) also provides a network of diverse intellectual, financial, and physical resources to help develop new initiatives, projects, and collaborations. For more information of CEI, please visit: https://ccrod.cancer.gov/confluence/display/COEI/Home.
The NOB also offers collaborative opportunities and resources through its various laboratory programs, encompassing areas of research in cell biology, genomics, and metabolomics, as well as its pre-clinical translational research program. For more information of NOB, please visit: https://ccr.cancer.gov/Neuro-Oncology-Branch.
The successful candidate should have a Ph.D. or equivalent doctoral degree and a well-established track record of publications in the area of immunology/immunotherapy. Candidates will be evaluated on their educational background, scholarly work, leadership and mentoring activities, and experience with immunology/immunotherapy research. Salary is commensurate with education and experience. Candidates may be U.S. citizens, U.S. permanent residents, or eligible for a visa that will enable work in the U.S.
Please submit curriculum vitae and statement of research interests and future plans to: http://irp-positions.nih.gov/job/NOBImmunology. Review of applications will begin on or about July 1, 2018 and the position will remain open until filled.
HHS, NIH, and NCI are Equal Opportunity Employers.
The NIH and NCI are dedicated to building a diverse community in its training and employment programs and encourages the application and nomination of qualified women, minorities, and individuals with disabilities.
Gene Therapies Branch and Cell Therapies Branch in Division of Cellular and Gene Therapies (DCGT), Office of Tissues and Advanced Therapies, Food and Drug Administration are recruiting full-time review scientists. Successful candidates will perform scientific review, interpretation, and documentation of product manufacturing data to evaluate the safety and quality of gene and/or cell therapy products in regulatory submissions to FDA. Candidates are expected to be proficient in applying relevant scientific knowledge and research experience to support multi-disciplinary scientific and regulatory reviews of regulatory submissions. Successful candidates may also have opportunities to contribute to guidance and policy development activities relevant to gene and/or cell therapy.
DCGT is strongly committed to bringing FDA and other scientists, patient advocates, and the public together in partnership to develop new therapies for the 21st Century, while protecting human subjects and ensuring product safety. The candidate will be a part of a cutting-edge and fast-paced scientific and regulatory environment.
These positions will be filled through FDA's Service Fellowship program. The appointment is for up to four years with opportunities for renewal. Applications will be accepted from U.S. citizens or Lawful Permanent Residents (green card holders) only. No previous Federal experience is required. Appointment does not confer any entitlement to a position in the competitive service, and there is no entitlement to Merit Systems Protection Board (MSPB) appeals rights.
QUALIFICATIONS: Ph.D. or equivalent advanced degree in the areas specified below. Postdoctoral experience highly preferred. In addition, you must have strong collaborative skills, excellent written and oral communication skills, and evidence of leadership potential. Knowledge of federal regulations applicable to drugs, biologics, and devices is helpful but not a requirement for consideration.
SALARY: Salary commensurate with education/experience.
LOCATION: FDA White Oak campus, Silver Spring, Maryland, U.S.A.
HOW TO APPLY: Submit a statement of interest for a gene therapy or cell therapy review scientist position, resume or curriculum vitae (CV) detailing relevant experience, transcripts, names/contact information for three references, proof of U.S. citizenship or lawful permanent residency status, and other supporting documentations to Ms. Teslyn Hudgins at firstname.lastname@example.org. Applications will be accepted through August 27, 2018. However, candidates will be considered as received. For best consideration, please submit your application as soon as possible.
The University of Washington Department of Medicine, Division of Medical Oncology and Fred Hutchinson Cancer Research Center, Clinical Research Division (UW/FHCRC) are jointly recruiting for a full-time faculty member to join our clinical research group focused on Melanoma, Merkel cell and Kidney cancer. The position may be at the Assistant (0113), Associate (0112) or full Professor level (0111), dependent on previous experience, on the clinician/teacher pathway without tenure due to funding. Requirements include MD (or foreign equivalent) and fellowship training in Medical Oncology (or foreign equivalent).
Our collaborative clinical and translational research group is focused on Melanoma, Merkel cell, and Kidney cancer, with special interest in novel immunotherapies. The successful candidate should have a strong interest in providing cutting edge patient care through clinical research trials. The selected candidate will have the opportunity to participate in the ongoing clinical and laboratory research projects of the group in the cancers noted above, and will be provided adequate resources and mentorship to develop his/her own clinical research interests.
The position will also involve participation in the clinical and instructional activities of the Division of Medical Oncology. In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE), or equivalent as determined by the Secretary of Health and Human Services. University of Washington faculty engage in teaching, research, and service.
The position will remain open until filled.
Interested candidates should submit a CV and a concise description of their training, research activities and career goals to John A. Thompson, MD, Seattle Cancer Care Alliance, 825 Eastlake Ave. East, mailstop CE2-102, Seattle, WA 98109 or email@example.com.
University of Washington is an affirmative action and equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, gender expression, national origin, age, protected veteran or disabled status, or genetic information.
We are looking for a life-sciences graduate student or post-doc that preferably has a good understanding of immunology and immuno-oncology to work part-time remotely for Amp biotech stock research (ampbioresearch.com) helping us to research various immunology and immune-oncology biotechnology companies. The research involves comparing technical clinical and pre-clinical trial design and results related to various drug candidates in clinical development. The research might also include looking at the market for various drug candidates and assisting us in preparing written reports on our analysis. Please note that this will be a independent consultant 1099 position. Approximate hourly rate will be based on research experience and academic progress. Target rate is $25/hr for late stage grad student or post-doc.
The candidate must have a positive attitude and be able to communicate well orally and in writing. The candidate must be efficient and disciplined while working remotely, and have a high speed internet connection and computer. We are a virtual company. The candidate must be able to manage priorities and meet deadlines. The candidate must follow systems and work well with other team members. Strong academic performance is required. If you are interested, please send your resume and a brief email cover letter mentioning this post, to firstname.lastname@example.org.
The professional we select will direct all activities within the Northwestern Medicine cell-processing laboratory and cell-manufacturing laboratory. Responsible for all administrative operations and quality assurance, providing leadership in the development and implementation of all cell-processing procedures with the laboratories, including compliance with regulating bodies.
Northwestern Medicine offers exceptional resources, education, growth opportunities, and benefits-including premier health insurance featuring our renowned physician network.
For more information and to apply, please visit us online at: www.nm.org (job #14980).
YOUR TASKS AND RESPONSIBILITIES
The primary responsibilities of this role, Early Clinical Lead – Immuno Oncology, are to:
WHO YOU ARE
Your success will be driven by your demonstration of our LIFE values. More specifically related to this position, Bayer seeks an incumbent who possesses the following:
The FDA’s Office of Tissues and Advanced Therapies (OTAT), Division of Cellular and Gene Therapies (DCGT) is recruiting a senior scientist who will serve as Chief of Cell Therapies Branch to provide a programmatic supervision and direction on the scientific and regulatory review of the manufacture and control of complex cellular products intended for a therapeutic use in human.
The incumbent of this position will:
REQUIREMENTS:U.S. Citizenship is required for federal employment; This position may require occasional travel; Selective service registration is required for males born after 12/31/1959; A security investigation and/or 1-year supervisory probationary period may be required; Only experience gained by the announcement closing date will be considered.
QUALIFICATIONS: PhD is preferred but is not a requirement.
In order to qualify for Supervisory Interdisciplinary Scientist, 0401/0403, at GS-15, all applicants must meet the following basic educational requirement for the particular series of interest:
Biology, GS-0401: Degree in biological sciences, agriculture, natural resource management, chemistry, or related disciplines appropriate to the position. – OR – A combination of education and experience with courses as shown above equivalent to a major plus appropriate experience or additional education.
Microbiology, GS-0403: Degree in microbiology; or biology, chemistry, or basic medical science that included at least 20 semester hours in microbiology and other subjects related to the study of microorganisms, and 20 semester hours in the physical and mathematical sciences combining course work in organic chemistry or biochemistry, physics, and college algebra, or their equivalent. – OR – A combination of education and experience with courses equivalent to a major in microbiology, biology, chemistry, or basic medical science that included courses as shown above, plus appropriate experience or additional education.
In addition to meeting one of the basic educational requirements above, all applicants must meet the specialized experience requirement below:
In order to qualify for the position of Supervisory IDS, GS-0401/0403-15, you must have one year of specialized experience, equivalent to the GS-14 in the Federal service which includes providing programmatic direction and oversight on scientific and regulatory review and documentation of the manufacture and control of novel and complex cellular products which may include, but not limited to, somatic cell therapy, stem cell therapy, cellular immunotherapy, tissue engineering and regenerative medicine advanced therapy, and xenotransplantation products which the Branch is responsible for regulatory review and action.
SALARY: $134,789 to $164,200 per year
LOCATION: This position is located in the Center for Biologics Evaluation and Research (CBER), Office of Tissue and Advanced Therapies (OTAT), Division of Cellular and Gene Therapies (DCGT) located in Silver Spring, MD.
HOW TO APPLY: Please review the official job opportunity announcement on USAJobs.gov for additional requirements and application procedures. Applications must be received by applying to the official job opportunity announcement located at https://www.usajobs.gov/GetJob/ViewDetails/493411100. Please pay careful attention to the Qualifications and Required Documents sections of the announcement.
The Mayo Clinic Department of Immunology is seeking applications from outstanding basic science or translational investigators.
The ideal candidate will be a laboratory-based investigator whose research program and interests innovatively impact the field of cancer immunotherapy. Specific areas of interest include innate and adaptive immunity to cancer, and cancer immunotherapy (checkpoint blockade, vaccine or T cell transfer).
Candidates holding a doctoral degree (PhD, MD/PhD, or MD) at all levels of academic rank will be considered for this faculty position. Junior investigators should have a strong publication record and evidence of successful competition for external funding is preferred. Senior candidates must have a strong publication record and history of NIH- or equivalent extramural funding. The selected individual is expected to develop and/ or maintain a nationally and internationally recognized extramurally funded research program. Collaborative and translational opportunities are available and strongly encouraged, such as participation in NCI Specialized Programs of Research Excellence (SPORE) grants, integrating all three Mayo sites (AZ, MN, and FL). Mayo Clinic offers a highly competitive compensation package with sustained intramural salary support, outstanding laboratory facilities, capital equipment funding, technical and computational resources, and exceptional benefits. The Mayo Clinic Department of Immunology is a three-site department with 41 independent investigators. The department sponsors outstanding NIH-funded PhD and MD/PhD training programs, and provides an interactive, collaborative environment for the investigation of basic mechanisms of immunity and the translation of new insights to the treatment of human disease.
MAYO CLINIC is ranked number one overall nation-wide as well as in more specialties than any other hospital in the nation for 2017-2018 by the U.S. News and World Report. We are an integrated, multidisciplinary academic medical center with an NCI-sponsored Comprehensive Cancer Center, and programs in medical education and research that span across three group practice sites. We support a vibrant research enterprise, with programs in basic, translational, clinical, and population sciences. In 2017, the institution received nearly $450 million in extramural research awards, supplemented with over $304 million of institutional support. Mayo Clinic has
a large number of world class faculty, laboratory and state-of-the-art shared resource facilities across all 3 sites, including those for microscopy and imaging, cell and molecular biology, animal models, biomedical engineering and mathematics, a Mouse Modeling Facility, Molecular and Microscopic Core Facilities, and unique Human Disease Tissue Banks.
CLICK HERE to learn more and apply.
Applications should include a cover letter, CV, and a statement of research interests.
Mayo Foundation is an affirmative action and equal opportunity educator and employer. Post offer/pre-employment drug screening is required. ©2018 Mayo Foundation for Medical Education and Research
Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200 clinical trials in 19 different types of cancer.
AbbVie is expanding its oncology hub on the West Coast, with three sites in the San Francisco Bay Area (Redwood City, South San Francisco, and Sunnyvale) focused on the discovery and development of novel oncology therapies. More than 1,000 AbbVie scientists, clinicians, and product developers with strong entrepreneurial roots work across these three sites. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. This position is based at Stemcentrx, AbbVie's South San Francisco, CA location.
Senior Scientist I/II - Molecular Biology/Cancer Genetics
As part of a talented and multi-disciplinary team advancing exciting new approaches to drug discovery and development, AbbVie Stemcentrx is looking for a highly motivated scientist with direct experience in cancer genetics and molecular biology. AbbVie is a global, research-based biopharmaceutical company with a strong focus in oncology and its subsidiary Stemcentrx is a leader in identifying novel cancer stem cell targets and developing targeted antibody drug conjugate (ADC) therapies in oncology. The successful candidate will contribute to annotating and predicting the impact of genetic variants in tumors, and lead efforts to integrate gene mutation, gene expression, copy number variation, methylation, proteomics and other datasets across our large patient derived xenograft (PDX) bank of tumors, to aid in target and biomarker identification. Additionally, this scientist will lend expert molecular biology insights to confirm transcript isoform(s) expressed in tumor and normal tissues, ensure correct cloning of species homologs and consider single nucleotide polymorphisms (SNPs) that could alter antibody binding.
Key Responsibilities Include:
**Equal Opportunity Employer Minorities/Women/Veterans/Disabled**
URL for your website or original job posting: https://ars2.equest.com/?response_id=05cbb86aa2fe5cc72c019e211dd6d872
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com